Background: Thrombopoietin (TPO) is a cytokine mainly produced in the liver that regulate humoral control mechanism of thrombopoesis. Presumably, TPO production is decrease in patients with liver cirrhosis which interfere platelet production. The aim of this study was to identify the correlation between serum TPO levels and the clinical stage of liver cirrhosis.Method: With analytical cross sectional design, this sudy analyzed the correlation between the serum TPO level and the clinical stage of liver cirrhosis according to Child-Pugh classification in 32 liver cirrhosis patients and 30 healthy subjects from March 2015 to August 2015. The serum level of TPO was examined using the Quantikine human TPO immunoassay.Results: There were 13 femal...
Background. Tumor necrosis factor-α is a major cytokine involved in various forms of liver injury. ...
Background: Cirrhosis hepatic is a chronic liver disease characterized by the replacement of liver t...
OBJECTIVES: Thrombocytopenia is a hallmark for patients with cirrhosis and it is perceived as a risk...
Background: Thrombopoietin (TPO) is a cytokine mainly produced in the liver that regulate humoral co...
Background: Thrombopoetin (TPO) is a cytokine mainly produced in the liver and is the principal regu...
Background/aims: Thrombocytopenia in patients with advanced liver disease may stem from a deficient ...
Background/Aims: Platelet production is regulated by thrombopoietin (TPO), which is primarily synthe...
Thrombocytopenia occurs frequently in patients with cirrhosis. The immature platelet fraction (IPF%)...
<div><p>Background and aims</p><p>Thrombocytopenia occurs frequently in patients with cirrhosis. The...
Aim: Liver cirrhosis isa process characterized by fibrosis and normal liver structure is replaced wi...
Liver cirrhosis is described as a diffused pathological process which marked with fibrosis and archi...
BACKGROUND & AIMS: Thrombocytopenia is common in liver cirrhosis (LC) but the mechanisms are not...
Background: Thrombocytopenia is a common manifestation of liver cirrhosis (LC), but the underlying m...
Introduction: Serum Insulin-like Growth Factor-1 level decreases in cirrhosis due to reduced growth ...
Thrombocytopenia is a common hematological abnormality in patients with chronic liver disease, and i...
Background. Tumor necrosis factor-α is a major cytokine involved in various forms of liver injury. ...
Background: Cirrhosis hepatic is a chronic liver disease characterized by the replacement of liver t...
OBJECTIVES: Thrombocytopenia is a hallmark for patients with cirrhosis and it is perceived as a risk...
Background: Thrombopoietin (TPO) is a cytokine mainly produced in the liver that regulate humoral co...
Background: Thrombopoetin (TPO) is a cytokine mainly produced in the liver and is the principal regu...
Background/aims: Thrombocytopenia in patients with advanced liver disease may stem from a deficient ...
Background/Aims: Platelet production is regulated by thrombopoietin (TPO), which is primarily synthe...
Thrombocytopenia occurs frequently in patients with cirrhosis. The immature platelet fraction (IPF%)...
<div><p>Background and aims</p><p>Thrombocytopenia occurs frequently in patients with cirrhosis. The...
Aim: Liver cirrhosis isa process characterized by fibrosis and normal liver structure is replaced wi...
Liver cirrhosis is described as a diffused pathological process which marked with fibrosis and archi...
BACKGROUND & AIMS: Thrombocytopenia is common in liver cirrhosis (LC) but the mechanisms are not...
Background: Thrombocytopenia is a common manifestation of liver cirrhosis (LC), but the underlying m...
Introduction: Serum Insulin-like Growth Factor-1 level decreases in cirrhosis due to reduced growth ...
Thrombocytopenia is a common hematological abnormality in patients with chronic liver disease, and i...
Background. Tumor necrosis factor-α is a major cytokine involved in various forms of liver injury. ...
Background: Cirrhosis hepatic is a chronic liver disease characterized by the replacement of liver t...
OBJECTIVES: Thrombocytopenia is a hallmark for patients with cirrhosis and it is perceived as a risk...